On March 29, 2007 the FDA announced the withdrawal of pergolide from the market, placing the health and well being of all horses diagnosed with Equine Cushing's Disease (pituitary pars intermedia dysfunction or PPID) in jeopardy. Thanks to those who contributed their time and efforts, the continued availability of pergolide is ensured in the U.S. - for now. (See the May 11 FDA/CVM announcement.)
Wednesday, May 9, 2007
New Jersey Readers Get the Pergolide Message!
Hunterdon County Democrat story features Kellie and her TB eventing horse Kelton.
"Horse owners are hoping they can convince both the FDA and the manufacturers to keep the drug available to veterinarians, too. It was not known how many horses are being treated with pergolide, but it is possible that more horses use it than people."
Read the story and see Kellie and Kelton here:
http://www.print2webcorp.com/news/njcom/hunterdon/horsenews/20070501/p16.asp?st=p16_s1.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment